These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32874133)

  • 1. Identification of potential biomarkers and candidate small molecule drugs in glioblastoma.
    Lu WC; Xie H; Yuan C; Li JJ; Li ZY; Wu AH
    Cancer Cell Int; 2020; 20():419. PubMed ID: 32874133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule drug discovery for glioblastoma treatment based on bioinformatics and cheminformatics approaches.
    Feng L; Zhu S; Ma J; Huang J; Hou X; Qiu Q; Zhang T; Wan M; Li J
    Front Pharmacol; 2024; 15():1389440. PubMed ID: 38681202
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC12A5 as a novel potential biomarker of glioblastoma multiforme.
    Chen J; Wang H; Deng C; Fei M
    Mol Biol Rep; 2023 May; 50(5):4285-4299. PubMed ID: 36917367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of Potential Glioblastoma Multiforme-Related miRNA-mRNA Regulatory Network.
    Lou W; Ding B; Xu L; Fan W
    Front Mol Neurosci; 2019; 12():66. PubMed ID: 30971889
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-negative matrix factorization and differential expression analyses identify hub genes linked to progression and prognosis of glioblastoma multiforme.
    Akçay S; Güven E; Afzal M; Kazmi I
    Gene; 2022 May; 824():146395. PubMed ID: 35283227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.
    Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J
    Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of core genes as potential biomarkers for predicting progression and prognosis in glioblastoma.
    Zeng J; Hua S; Liu J; Mungur R; He Y; Feng J
    Front Genet; 2022; 13():928407. PubMed ID: 36238156
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioinformatics analysis of potential core genes for glioblastoma.
    Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma.
    Liu Z; Wang X; Yang G; Zhong C; Zhang R; Ye J; Zhong Y; Hu J; Ozal B; Zhao S
    J Cell Biochem; 2020 Jul; 121(7):3502-3515. PubMed ID: 32277520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme.
    Yang J; Wang L; Xu Z; Wu L; Liu B; Wang J; Tian D; Xiong X; Chen Q
    Front Genet; 2020; 11():253. PubMed ID: 32296458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.
    Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis of high-throughput data to validate potential novel biomarkers and small molecule drugs for glioblastoma multiforme.
    Qi F; Li Q; Lu X; Chen Z
    J Int Med Res; 2020 Jul; 48(7):300060520924541. PubMed ID: 32634050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key candidate genes and pathways in glioblastoma by integrated bioinformatical analysis.
    Li L; Liu X; Ma X; Deng X; Ji T; Hu P; Wan R; Qiu H; Cui D; Gao L
    Exp Ther Med; 2019 Nov; 18(5):3439-3449. PubMed ID: 31602219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis.
    Wu Q; Zhang B; Sun Y; Xu R; Hu X; Ren S; Ma Q; Chen C; Shu J; Qi F; He T; Wang W; Wang Z
    Onco Targets Ther; 2019; 12():3545-3563. PubMed ID: 31190860
    [No Abstract]   [Full Text] [Related]  

  • 19. Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technology.
    Cui K; Chen JH; Zou YF; Zhang SY; Wu B; Jing K; Li LW; Xia L; Sun C; Dong YL
    Technol Cancer Res Treat; 2021; 20():1533033821990368. PubMed ID: 34018447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
    Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
    Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.